2023 annual financial data

PTC Therapeutics 2023 Financial results

Direct answer

Revenue was 937,822,000 USD.

Operating income was -439,502,000 USD and net income was -626,604,000 USD.
Operating cash flow was -158,418,000 USD.

Get free PTC Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
937,822,000 USD
Operating income
-439,502,000 USD
Net income
-626,604,000 USD
Operating cash flow
-158,418,000 USD